Fig. 2From: One of the 5-aminosalicylates drug, mesalamine as a drug repurposing lead against breast cancerDocked images of mTOR, ALOX5, and Topoisomerase II with mesalamine, showing various interactions within the complex. 3D image of binding of the ligand with A mTOR, B ALOX5, C Topoisomerase II. 2D diagram involving various amino acid residues after docking of the ligand with a mTOR, b ALOX5, c Topoisomerase IIBack to article page